FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308438817> ?p ?o ?g. }

• W4308438817 endingPage "63" @default.
• W4308438817 startingPage "57" @default.
• W4308438817 abstract "Objective: Serum tumor markers has been evolved as an effective tool to determine prognosis and treatment efficiency in different types of cancer. The aim of this study was to explore the chemotherapy monitoring efficiency and prognostic sensitivity of tumor associated cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) markers in early (II) and late (IV) clinical stages of breast cancer patients.&#x0D; &#x0D; Methods: CA 15-3 and CEA serum levels were assessed in 56 breast cancer patients at early II (n = 26) and late IV (n = 30) clinical stages with primary inclusion criteria: who received adjuvant chemotherapy AC (Adriamycin & Cyclophosphamide) or AC-T (Adriamycin & Cyclophosphamide followed by Taxane) regimes and human epidermal growth factor receptor 2 (HER2) negative by using particle enhanced turbid metric assay.&#x0D; &#x0D; Results: Higher elevation of CA 15-3 as compared to CEA in pre-treatment group of breast cancer patients as compared to healthy control was observed. Late-stage patients showed higher positive serum levels as compared to early-stage one for both markers with preference of CA 15-3 over CEA. AC-T chemotherapy regime treatment in both clinical stages revealed significantly higher level of both markers as compared to AC regime with preference of CA 15-3 over CEA at late stage. Both markers levels were significantly higher in late-stage group as compared with early-stage ones for both chemotherapy regimens.&#x0D; &#x0D; Conclusion: CA 15-3 is more efficient as prognostic monitoring marker in comparison with CEA and revels a positive connection between chemotherapy regime system and staging, more observed in late-stage.&#x0D;" @default.
• W4308438817 created "2022-11-11" @default.
• W4308438817 creator A5019886146 @default.
• W4308438817 date "2022-11-07" @default.
• W4308438817 modified "2023-10-03" @default.
• W4308438817 title "Diagnostic impact of CEA and CA 15-3 on monitoring chemotherapy of breast cancer patients" @default.
• W4308438817 cites W1566210456 @default.
• W4308438817 cites W1906102489 @default.
• W4308438817 cites W1965332644 @default.
• W4308438817 cites W1966807692 @default.
• W4308438817 cites W1968750998 @default.
• W4308438817 cites W1968813883 @default.
• W4308438817 cites W1979097335 @default.
• W4308438817 cites W1983418628 @default.
• W4308438817 cites W1985213644 @default.
• W4308438817 cites W1994007039 @default.
• W4308438817 cites W2008046286 @default.
• W4308438817 cites W2016364907 @default.
• W4308438817 cites W2020256830 @default.
• W4308438817 cites W2032515679 @default.
• W4308438817 cites W2037507891 @default.
• W4308438817 cites W2047242308 @default.
• W4308438817 cites W2052129612 @default.
• W4308438817 cites W2054037411 @default.
• W4308438817 cites W2062116979 @default.
• W4308438817 cites W2065236043 @default.
• W4308438817 cites W2069368331 @default.
• W4308438817 cites W2070522239 @default.
• W4308438817 cites W2087678940 @default.
• W4308438817 cites W2101954781 @default.
• W4308438817 cites W2117305280 @default.
• W4308438817 cites W2119392662 @default.
• W4308438817 cites W2124910188 @default.
• W4308438817 cites W2139248078 @default.
• W4308438817 cites W2153766359 @default.
• W4308438817 cites W2155326178 @default.
• W4308438817 cites W2170481258 @default.
• W4308438817 cites W2171858932 @default.
• W4308438817 cites W2239506532 @default.
• W4308438817 cites W230099372 @default.
• W4308438817 cites W2400240881 @default.
• W4308438817 cites W2406145545 @default.
• W4308438817 cites W2473657539 @default.
• W4308438817 cites W2513966554 @default.
• W4308438817 cites W2597872842 @default.
• W4308438817 cites W2761065707 @default.
• W4308438817 cites W3007243671 @default.
• W4308438817 cites W7729919 @default.
• W4308438817 cites W2407182056 @default.
• W4308438817 cites W43766594 @default.
• W4308438817 doi "https://doi.org/10.33393/jcb.2022.2446" @default.
• W4308438817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36381348" @default.
• W4308438817 hasPublicationYear "2022" @default.
• W4308438817 type Work @default.
• W4308438817 citedByCount "5" @default.
• W4308438817 countsByYear W43084388172023 @default.
• W4308438817 crossrefType "journal-article" @default.
• W4308438817 hasAuthorship W4308438817A5019886146 @default.
• W4308438817 hasBestOaLocation W43084388171 @default.
• W4308438817 hasConcept C121608353 @default.
• W4308438817 hasConcept C126322002 @default.
• W4308438817 hasConcept C143998085 @default.
• W4308438817 hasConcept C146357865 @default.
• W4308438817 hasConcept C151730666 @default.
• W4308438817 hasConcept C2776694085 @default.
• W4308438817 hasConcept C2776755627 @default.
• W4308438817 hasConcept C2777387746 @default.
• W4308438817 hasConcept C2777511904 @default.
• W4308438817 hasConcept C530470458 @default.
• W4308438817 hasConcept C71924100 @default.
• W4308438817 hasConcept C86803240 @default.
• W4308438817 hasConcept C90924648 @default.
• W4308438817 hasConceptScore W4308438817C121608353 @default.
• W4308438817 hasConceptScore W4308438817C126322002 @default.
• W4308438817 hasConceptScore W4308438817C143998085 @default.
• W4308438817 hasConceptScore W4308438817C146357865 @default.
• W4308438817 hasConceptScore W4308438817C151730666 @default.
• W4308438817 hasConceptScore W4308438817C2776694085 @default.
• W4308438817 hasConceptScore W4308438817C2776755627 @default.
• W4308438817 hasConceptScore W4308438817C2777387746 @default.
• W4308438817 hasConceptScore W4308438817C2777511904 @default.
• W4308438817 hasConceptScore W4308438817C530470458 @default.
• W4308438817 hasConceptScore W4308438817C71924100 @default.
• W4308438817 hasConceptScore W4308438817C86803240 @default.
• W4308438817 hasConceptScore W4308438817C90924648 @default.
• W4308438817 hasLocation W43084388171 @default.
• W4308438817 hasLocation W43084388172 @default.
• W4308438817 hasLocation W43084388173 @default.
• W4308438817 hasOpenAccess W4308438817 @default.
• W4308438817 hasPrimaryLocation W43084388171 @default.
• W4308438817 hasRelatedWork W2092771806 @default.
• W4308438817 hasRelatedWork W2365277249 @default.
• W4308438817 hasRelatedWork W2367105124 @default.
• W4308438817 hasRelatedWork W2379009234 @default.
• W4308438817 hasRelatedWork W2380201224 @default.
• W4308438817 hasRelatedWork W2388730008 @default.
• W4308438817 hasRelatedWork W2513966554 @default.
• W4308438817 hasRelatedWork W2792941486 @default.

• next